Clinical outcomes of catheter ablation remain suboptimal in patients with atrial fibrillation(AF),particularly in those with persistent AF,despite decades of research,clinical trials,and technological advancements.Rec...Clinical outcomes of catheter ablation remain suboptimal in patients with atrial fibrillation(AF),particularly in those with persistent AF,despite decades of research,clinical trials,and technological advancements.Recently,pulsed-field ablation(PFA),a promising non-thermal technology,has been introduced to improve procedural outcomes.Its unique feature of myocardial selectivity offers safety advantages by avoiding potential harm to vulnerable adjacent structures during AF ablation.However,despite the global enthusiasm within the electro-physiology community,recent data indicate that PFA is still far from being a“magic wand”for addressing such a complex and challenging arrhythmia as AF.More progress is needed in mapping processes rather than in ablation technology.This editorial reviews relevant available data and explores future research directions for PFA.展开更多
文摘Clinical outcomes of catheter ablation remain suboptimal in patients with atrial fibrillation(AF),particularly in those with persistent AF,despite decades of research,clinical trials,and technological advancements.Recently,pulsed-field ablation(PFA),a promising non-thermal technology,has been introduced to improve procedural outcomes.Its unique feature of myocardial selectivity offers safety advantages by avoiding potential harm to vulnerable adjacent structures during AF ablation.However,despite the global enthusiasm within the electro-physiology community,recent data indicate that PFA is still far from being a“magic wand”for addressing such a complex and challenging arrhythmia as AF.More progress is needed in mapping processes rather than in ablation technology.This editorial reviews relevant available data and explores future research directions for PFA.
